Alexander Bruckmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Bruckmann has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Elizabeth J. Brisbois
School of Chemical, Materials, and Biomedical Engineering, University of Georgia, 302 East Campus Rd., Athens, GA, 30602, USA
2 shared publications - Hitesh Handa
University of Georgia
2 shared publications Aasma Sapkota
School of Chemical, Materials, & Biomedical Engineering, College of Engineering
1 shared publication- Adam Brooks Goodman
University of Georgia
1 shared publication - Anna L. Rieck
Karlsruhe Institute for Technology (KIT) Institute for Biological Interfaces (IBG 1) Hermann‐von‐Helmholtz‐Platz 1 D‐76344 Eggenstein‐Leopoldshafen Germany
1 shared publication - Britta Nestler
Institute for Applied Materials—Microstructure Modelling and Simulation (IAM-MMS), Karlsruhe Institute of Technology (KIT) 1 , Strasse am Forum 7, 76131 Karlsruhe
1 shared publication
Latest Publications
- Open Access
- 27 September 2026
- Published by Wiley in Advanced Science
- p. e77846
Smartphone‐Guided Visible Light Modulation of RSNOs for Antimicrobial Activity via Controlled Nitric Oxide Release
Methicillin‐resistant Staphylococcus aureus (MRSA) remains a major contributor to antimicrobial‐resistant infections worldwide. Antimicrobial blue light (aBL, ∼405‐450 nm) generates intracellular reactive oxygen species through excitation of endogenous chromophores, while nitric oxide (NO) induces complementary nitrosative and oxidative damage. S ‐nitrosothiols (RSNOs) provide a platform for visible‐light‐triggered NO release. Here, a synergistic antimicrobial strategy combining aBL with RSNO coatings was developed to simultaneously generate reactive oxygen and nitrogen species and evaluated against bacterial and fungal pathogens. Four RSNO donors ( S ‐nitroso‐ N ‐acetylpenicillamine (SNAP), S ‐nitrosoglutathione (GSNO), S ‐nitroso‐1‐adamantanethiol (SNAT), and S ‐nitrosotriphenylmethanethiol (Ph 3 ‐CSNO)) were incorporated into catheter insert coatings and exhibited distinct, wavelength‐dependent NO‐release profiles, with aBL enhancing NO release for all formulations. SNAT showed the greatest photochemical response, with a 235% increase in steady‐state NO flux under irradiation. The combined generation of reactive species produced potent broad‐spectrum antimicrobial activity against Staphylococcus aureus , MRSA, Escherichia coli , and Candida albicans , achieving >4‐log reductions in microbial viability with all RSNO‐coated inserts under aBL after 24 h. In vivo, SNAT‐coated inserts significantly reduced S. aureus colonization in a rabbit infection model, achieving up to a 2.35‐log reduction in bacterial burden, demonstrating that light‐triggered NO delivery combined with aBL provides an antibiotic‐independent strategy for preventing device‐associated infections.
- 27 September 2026
- Published by Wiley in Advanced Science
- p. e77846
Open AccessSmartphone‐Guided Visible Light Modulation of RSNOs for Antimicrobial Activity via Controlled Nitric Oxide Release
Methicillin‐resistant Staphylococcus aureus (MRSA) remains a major contributor to antimicrobial‐resistant infections worldwide. Antimicrobial blue light (aBL, ∼405‐450 nm) generates intracellular reactive oxygen species through excitation of endogenous chromophores, while nitric oxide (NO) induces complementary nitrosative and oxidative damage. S ‐nitrosothiols (RSNOs) provide a platform for visible‐light‐triggered NO release. Here, a synergistic antimicrobial strategy combining aBL with RSNO coatings was developed to simultaneously generate reactive oxygen and nitrogen species and evaluated against bacterial and fungal pathogens. Four RSNO donors ( S ‐nitroso‐ N ‐acetylpenicillamine (SNAP), S ‐nitrosoglutathione (GSNO), S ‐nitroso‐1‐adamantanethiol (SNAT), and S ‐nitrosotriphenylmethanethiol (Ph 3 ‐CSNO)) were incorporated into catheter insert coatings and exhibited distinct, wavelength‐dependent NO‐release profiles, with aBL enhancing NO release for all formulations. SNAT showed the greatest photochemical response, with a 235% increase in steady‐state NO flux under irradiation. The combined generation of reactive species produced potent broad‐spectrum antimicrobial activity against Staphylococcus aureus , MRSA, Escherichia coli , and Candida albicans , achieving >4‐log reductions in microbial viability with all RSNO‐coated inserts under aBL after 24 h. In vivo, SNAT‐coated inserts significantly reduced S. aureus colonization in a rabbit infection model, achieving up to a 2.35‐log reduction in bacterial burden, demonstrating that light‐triggered NO delivery combined with aBL provides an antibiotic‐independent strategy for preventing device‐associated infections.
- Open Access
- 24 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Reactive Multifunctional Ink for Hydrogel Fabrication and Cell-Laden 3D Printing via Incorporation of Strontium-Doped Bioactive Glass
Three-dimensional printing offers a powerful strategy for transformation of hydrogels into multifunctional scaffolds that can support cell growth and tissue regeneration. Here, we report a photo-crosslinkable gelatin and silk-based reactive ink that can be utilized for production of bulk hydrogels in addition to an additive manufacturing-enabled three-dimensional construct for osteoblast growth. The ink is engineered to provide dual therapeutic functionalities through (1) strontium ion delivery from dispersed strontium-doped bioactive glass (Sr-BG) and (2) the presence of active thiol groups post crosslinking that enables post-production modification/functionalization of the hydrogels through the thiol handle. Here, Sr-BG provides therapeutic levels of strontium ion release, supporting osteoblast growth within the hydrogel matrix. The proposed ink exhibits shear-thinning behavior conducive to extrusion-based bioprinting, enabling fabrication of cell-laden constructs that recapitulate complex tissue architectures. Printed Sr-BG-containing hydrogels support osteoblast metabolic activity over 7 days, attributed to synergistic effects of strontium-mediated signaling and a favorable matrix environment. Finally, this work extends nitrosation of active thiol groups as a pilot study for utilization of thiols post-production to produce antimicrobial hydrogels that demonstrated ∼83% reduction in viability of Staphylococcus aureus and ∼92% reduction with Escherichia coli when compared to non-functionalized controls. Collectively, this reactive ink provides a unique platform for production of bulk and cell-laden 3D-printed hydrogels in addition to the prospect of countless applications through post-production thiol modification.
- 24 June 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
Open AccessReactive Multifunctional Ink for Hydrogel Fabrication and Cell-Laden 3D Printing via Incorporation of Strontium-Doped Bioactive Glass
Three-dimensional printing offers a powerful strategy for transformation of hydrogels into multifunctional scaffolds that can support cell growth and tissue regeneration. Here, we report a photo-crosslinkable gelatin and silk-based reactive ink that can be utilized for production of bulk hydrogels in addition to an additive manufacturing-enabled three-dimensional construct for osteoblast growth. The ink is engineered to provide dual therapeutic functionalities through (1) strontium ion delivery from dispersed strontium-doped bioactive glass (Sr-BG) and (2) the presence of active thiol groups post crosslinking that enables post-production modification/functionalization of the hydrogels through the thiol handle. Here, Sr-BG provides therapeutic levels of strontium ion release, supporting osteoblast growth within the hydrogel matrix. The proposed ink exhibits shear-thinning behavior conducive to extrusion-based bioprinting, enabling fabrication of cell-laden constructs that recapitulate complex tissue architectures. Printed Sr-BG-containing hydrogels support osteoblast metabolic activity over 7 days, attributed to synergistic effects of strontium-mediated signaling and a favorable matrix environment. Finally, this work extends nitrosation of active thiol groups as a pilot study for utilization of thiols post-production to produce antimicrobial hydrogels that demonstrated ∼83% reduction in viability of Staphylococcus aureus and ∼92% reduction with Escherichia coli when compared to non-functionalized controls. Collectively, this reactive ink provides a unique platform for production of bulk and cell-laden 3D-printed hydrogels in addition to the prospect of countless applications through post-production thiol modification.
- Open Access
- 24 January 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (18)
Flow‐Induced Microfluidic Assembly for Advanced Biocatalysis Materials
Exploring the potential of microfluidic systems, this study presents a groundbreaking approach harnessing energy in microfluidic flows within a purpose‐built microreactor, enabling precise deposition of functional biomaterials. Upon optimizing reactor dimensions and integrating it into a microfluidic system, sequentially flow‐induced deposition of DNA hydrogels and transformation into DNA‐protein hybrid materials with SpyTag/SpyCatcher technology is investigated. However, limited functionalization rates restrict its viability for targeted biocatalytic processes. Therefore, the direct deposition of a phenolic acid decarboxylase is investigated, which is efficiently deposited but shows limited biocatalytic performance due to shear‐induced denaturation. This challenge is overcome by a two‐step immobilization process, resulting in microfluidic bioreactors demonstrating initial high space‐time yields of up to 7000 g L−1 d−1, but whose process stability proves unsatisfactory. However, by exploiting the principle of flow‐induced deposition to immobilize recombinant E. coli cells as functional living materials overexpressing biocatalytically relevant enzymes, bioreactors are produced that show equally high space‐time yields in continuous whole‐cell catalysis which remain constant over periods of up to 10 days. The insights gained offer optimization strategies for advanced functional materials and innovative reactor systems holding promise for applications in fundamental materials science, biosensing, and scalable production of microreactors for biocatalysis and bioremediation.
- 24 January 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (18)
Open AccessFlow‐Induced Microfluidic Assembly for Advanced Biocatalysis Materials
Exploring the potential of microfluidic systems, this study presents a groundbreaking approach harnessing energy in microfluidic flows within a purpose‐built microreactor, enabling precise deposition of functional biomaterials. Upon optimizing reactor dimensions and integrating it into a microfluidic system, sequentially flow‐induced deposition of DNA hydrogels and transformation into DNA‐protein hybrid materials with SpyTag/SpyCatcher technology is investigated. However, limited functionalization rates restrict its viability for targeted biocatalytic processes. Therefore, the direct deposition of a phenolic acid decarboxylase is investigated, which is efficiently deposited but shows limited biocatalytic performance due to shear‐induced denaturation. This challenge is overcome by a two‐step immobilization process, resulting in microfluidic bioreactors demonstrating initial high space‐time yields of up to 7000 g L−1 d−1, but whose process stability proves unsatisfactory. However, by exploiting the principle of flow‐induced deposition to immobilize recombinant E. coli cells as functional living materials overexpressing biocatalytically relevant enzymes, bioreactors are produced that show equally high space‐time yields in continuous whole‐cell catalysis which remain constant over periods of up to 10 days. The insights gained offer optimization strategies for advanced functional materials and innovative reactor systems holding promise for applications in fundamental materials science, biosensing, and scalable production of microreactors for biocatalysis and bioremediation.